0001104659-14-004519.txt : 20140128 0001104659-14-004519.hdr.sgml : 20140128 20140128153512 ACCESSION NUMBER: 0001104659-14-004519 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20131231 FILED AS OF DATE: 20140128 DATE AS OF CHANGE: 20140128 EFFECTIVENESS DATE: 20140128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tekla Capital Management LLC CENTRAL INDEX KEY: 0001300336 IRS NUMBER: 010628853 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-10950 FILM NUMBER: 14552754 BUSINESS ADDRESS: STREET 1: 2 LIBERTY SQUARE STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617 772-8500 MAIL ADDRESS: STREET 1: 2 LIBERTY SQUARE STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Hambrecht & Quist Capital Management LLC DATE OF NAME CHANGE: 20040811 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001300336 XXXXXXXX 12-31-2013 12-31-2013 false Tekla Capital Management LLC

2 LIBERTY SQUARE 9TH FLOOR BOSTON MA 02109

13F HOLDINGS REPORT 028-10950 N Laura Woodward 617-772-8500 /s/ Laura Woodward Boston MA 01-28-2014 0 57 952494 false INFORMATION TABLE 2 a14-3967_1informationtable.xml INFORMATION TABLE Accuray, Inc. Common 004397105 6375 731943 SH SOLE 731943 0 0 Acorda Therapeutics, Inc. Common 00484M106 3296 112881 SH SOLE 112881 0 0 Actavis plc Shares G0083B108 34559 205707 SH SOLE 205707 0 0 Aetna, Inc. Common 00817Y108 16931 246841 SH SOLE 246841 0 0 Akorn, Inc. Common 009728106 23048 935758 SH SOLE 935758 0 0 Alere, Inc. Common 01449J105 13378 369553 SH SOLE 369553 0 0 Alexion Pharmaceuticals, Inc. Common 015351109 49409 371329 SH SOLE 371329 0 0 Alkermes plc Shares G01767105 7923 194870 SH SOLE 194870 0 0 Allergan, Inc. Common 018490102 18503 166577 SH SOLE 166577 0 0 Alnylam Pharmaceuticals, Inc. Common 02043Q107 3133 48695 SH SOLE 48695 0 0 Amgen, Inc. Common 031162100 47050 412143 SH SOLE 412143 0 0 Auxilium Pharmaceuticals, Inc. Common 05334D107 3588 173020 SH SOLE 173020 0 0 Avanir Pharmaceuticals, Inc. Class A 05348P401 1364 406000 SH SOLE 406000 0 0 BioDelivery Sciences International, Inc. Common 09060J106 3427 581860 SH SOLE 581860 0 0 Biogen Idec, Inc. Common 09062X103 53707 191983 SH SOLE 191983 0 0 BioMarin Pharmaceutical Inc. Common 09061G101 18147 258241 SH SOLE 258241 0 0 Catamaran Corporation Common 148887102 6932 146000 SH SOLE 146000 0 0 Celgene Corporation Common 151020104 86177 510046 SH SOLE 510046 0 0 Centene Corporation Common 15135B101 3537 60000 SH SOLE 60000 0 0 Clovis Oncology, Inc. Common 189464100 1968 32658 SH SOLE 32658 0 0 Cubist Pharmaceuticals, Inc. Common 229678107 15618 226772 SH SOLE 226772 0 0 CVS Caremark Corporation Common 126650100 3843 53694 SH SOLE 53694 0 0 Endo Health Solutions Inc. Common 29264F205 8514 126215 SH SOLE 126215 0 0 Forest Laboratories, Inc. Common 345838106 8794 146500 SH SOLE 146500 0 0 Gilead Sciences, Inc. Common 375558103 113079 1504712 SH SOLE 1504712 0 0 Hologic, Inc. Common 436440101 9939 444687 SH SOLE 444687 0 0 IDEXX Laboratories, Inc. Common 45168D104 5985 56265 SH SOLE 56265 0 0 Illumina, Inc. Common 452327109 11487 103841 SH SOLE 103841 0 0 Impax Laboratories, Inc. Common 45256B101 8665 344683 SH SOLE 344683 0 0 Incyte Corporation Common 45337C102 29786 588300 SH SOLE 588300 0 0 Infinity Pharmaceuticals, Inc. Common 45665G303 4832 349899 SH SOLE 349899 0 0 IntelliPharmaCeutics International, Inc. Common 458173101 5195 1404000 SH SOLE 1404000 0 0 Ironwood Pharmaceuticals, Inc. Common 46333X108 8917 768050 SH SOLE 768050 0 0 Ishares Nasdaq Biotechnology ETF ETF 464287556 30904 136106 SH SOLE 136106 0 0 Macrogenics, Inc. Common 556099109 786 31857 SH SOLE 31857 0 0 McKesson Corporation Common 58155Q103 9178 56862 SH SOLE 56862 0 0 MEI Pharma, Inc. Common 55279B202 1954 243920 SH SOLE 243920 0 0 Merrimack Pharmaceuticals, Inc. Common 590328100 4043 757050 SH SOLE 757050 0 0 Molina Healthcare, Inc. Common 60855R100 3649 105000 SH SOLE 105000 0 0 Mylan, Inc. Common 628530107 21188 488209 SH SOLE 488209 0 0 Neurocrine Biosciences, Inc. Common 64125C109 3996 427790 SH SOLE 427790 0 0 NPS Pharmaceuticals, Inc. Common 62936P103 1907 62800 SH SOLE 62800 0 0 OncoGenex Pharmaceuticals, Inc. Common 68230A106 943 113100 SH SOLE 113100 0 0 Perrigo Company plc Common G97822103 33934 221124 SH SOLE 221124 0 0 PerkinElmer, Inc. Common 714046109 1084 26300 SH SOLE 26300 0 0 Pharmacyclics, Inc. Common 716933106 10366 98000 SH SOLE 98000 0 0 Puma Biotechnology, Inc. Common 74587V107 19238 185820 SH SOLE 185820 0 0 Regeneron Pharmaceuticals, Inc. Common 75886F107 71755 260699 SH SOLE 260699 0 0 Sagent Pharmaceuticals, Inc. Common 786692103 8102 319231 SH SOLE 319231 0 0 Shire plc Sponsored ADR 82481R106 21780 154153 SH SOLE 154153 0 0 Supernus Pharmaceuticals, Inc. Common 868459108 1062 140800 SH SOLE 140800 0 0 Teva Pharmaceutical Industries Ltd. ADR 881624209 12484 311476 SH SOLE 311476 0 0 Thermo Fisher Scientific, Inc. Common 883556102 1111 9980 SH SOLE 9980 0 0 UnitedHealth Group, Inc. Common 91324P102 6207 82436 SH SOLE 82436 0 0 Verastem, Inc. Common 92337C104 11615 1018827 SH SOLE 1018827 0 0 Vertex Pharmaceuticals, Inc. Common 92532F100 37132 499764 SH SOLE 499764 0 0 Waters Corporation Common 941848103 970 9700 SH SOLE 9700 0 0